epidemiology Archives - Drugs in Context

Home epidemiology

Review and expert opinion on MAFLD, oxidative stress and multifunctional management

Francesco Angelico, Diana Alcantara-Payawal, Rafiz Abdul Rani, Norlaila Mustafa, Nuntakorn Thongtang, Roongruedee Chaiteerakij, Chalermrat Bunchorntavakul, Apichard Sukonthasarn

Article Type

Review

Published

10 Jan 2024

This review summarizes the current knowledge about metabolic-associated fatty-liver disease (MAFLD) and reports the opinion of a group of experts on the increasing prevalence and burden of the disease in the southeast Asia region, the current journey of patients with MAFLD in developing countries, the role of oxidative stress and antioxidant treatment, and the importance of a multidisciplinary approach for early diagnosis and disease management.

Mycosis fungoides-type cutaneous T-cell lymphoma (MF-CTCL) epidemiology and treatment pathway in Spain: new insights for an accurate description

Paolo D’Agostino MSc, Alan Kent BSc (Hons), Eric Sharp MRSB, Fabian Schmidt Dipl.Kfm, Marco Turini MSc

Article Type

Original Research

Published

05 Aug 2020

This study aims to (1) provide an estimate for the prevalence of treated mycosis fungoides-type cutaneous T-cell lymphoma (MF-CTCL) patients in Spain, (2) describe the Spanish patient treatment pathways for MF-CTCL, including quantification of the distribution of patients between primary, secondary and tertiary care institutions, and (3) investigate and quantify the treatment preferences of physicians.